Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1978 Feb;41(2):135–139. doi: 10.1136/jnnp.41.2.135

Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

R J Chalmers, R H Johnson, H J Keogh, R N Nanda
PMCID: PMC492981  PMID: 24678

Abstract

The growth hormone (hGH) and prolactin (hPRL) responses to oral bromocriptine were studied in two groups of patients with Huntington's chorea and in seven healthy control subjects. The patients included six patients who had previously been treated with phenothiazines and six patients who had not received phenothiazine treatment. All medication was stopped 72 hours before the investigation which involved taking blood samples for up to 210 minutes after taking bromocriptine (2.5 mg). Plasma samples were analysed for hGH and hPRL. There was no significant difference in basal hGH concentrations between the patients and control subjects. The hGH response to bromocriptine varied in the individual patients but the concentrations were significantly lower in the patients compared with the controls between 160 and 210 minutes. The basal concentrations of hPRL were also not different, apart from the findings of elevated hPRL concentrations in three patients previously treated with phenothiazines. The patients and control subjects showed a consistent fall in hPRL concentrations after taking bromocriptine. The lower peak hGH response to bromocriptine found in the patients suggests that there may be an alteration of dopaminergic neurones mediating hGH release.

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARBEAU A. Dopamine and basal ganglia diseases. Arch Neurol. 1961 Jan;4:97–102. doi: 10.1001/archneur.1961.00450070099011. [DOI] [PubMed] [Google Scholar]
  2. Beumont P. J., Gelder M. G., Friesen G. H., Harris G. W., MacKinnon P. C., Mandelbrote B. M., Wiles D. H. The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea. Br J Psychiatry. 1974 May;124(0):413–419. doi: 10.1192/bjp.124.5.413. [DOI] [PubMed] [Google Scholar]
  3. Bird E. D., Chiappa S. A., Fink G. Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects. Nature. 1976 Apr 8;260(5551):536–538. doi: 10.1038/260536a0. [DOI] [PubMed] [Google Scholar]
  4. Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
  5. Camanni F., Massara F., Belforte L., Molinatti G. M. Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine. J Clin Endocrinol Metab. 1975 Mar;40(3):363–366. doi: 10.1210/jcem-40-3-363. [DOI] [PubMed] [Google Scholar]
  6. Del Pozo E., Del Re R. B., Varga L., Friesen H. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). J Clin Endocrinol Metab. 1972 Nov;35(5):768–771. doi: 10.1210/jcem-35-5-768. [DOI] [PubMed] [Google Scholar]
  7. Johnson A. M., Loew D. M., Vigouret J. M. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol. 1976 Jan;56(1):59–68. doi: 10.1111/j.1476-5381.1976.tb06959.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kartzinel R., Hunt R. D., Calne D. B. Bromocriptine in Huntington chorea. Arch Neurol. 1976 Jul;33(7):517–518. doi: 10.1001/archneur.1976.00500070059012. [DOI] [PubMed] [Google Scholar]
  9. Keogh H. J., Johnson R. H., Nanda R. N., Sulaiman W. R. Altered growth hormone release in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1976 Mar;39(3):244–248. doi: 10.1136/jnnp.39.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klawans H. L., Jr A pharmacologic analysis of Huntington's chorea. Eur Neurol. 1970;4(3):148–163. doi: 10.1159/000114017. [DOI] [PubMed] [Google Scholar]
  11. Meltzer H. Y., Fang V. S. The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry. 1976 Mar;33(3):279–286. doi: 10.1001/archpsyc.1976.01770030003001. [DOI] [PubMed] [Google Scholar]
  12. Parkes J. D., Marsden C. D., Donaldson I., Galea-Debono A., Walters J., Kennedy G., Asselman P. Bromocriptine treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1976 Feb;39(2):184–193. doi: 10.1136/jnnp.39.2.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Perry T. L., Hansen S., Kloster M. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med. 1973 Feb 15;288(7):337–342. doi: 10.1056/NEJM197302152880703. [DOI] [PubMed] [Google Scholar]
  14. Phillipson O. T., Bird E. D. Plasma growth hormone concentrations in Huntington's chorea. Clin Sci Mol Med. 1976 Jun;50(6):551–554. doi: 10.1042/cs0500551. [DOI] [PubMed] [Google Scholar]
  15. Reuter A. M., Kennes F., Gevaert Y., Franchimont P. Homologous radioimmunoassay for human prolactin. Int J Nucl Med Biol. 1976 Jan;3(1):21–28. doi: 10.1016/0047-0740(76)90005-x. [DOI] [PubMed] [Google Scholar]
  16. Sherman L., Kim S., Benjamin F., Kolodny H. D. Effect of chlorpromazine on serum growth-hormone concentration in man. N Engl J Med. 1971 Jan 14;284(2):72–74. doi: 10.1056/NEJM197101142840203. [DOI] [PubMed] [Google Scholar]
  17. Shoulson I., Kartzinel R., Chase T. N. Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology. 1976 Jan;26(1):61–63. doi: 10.1212/wnl.26.1.61. [DOI] [PubMed] [Google Scholar]
  18. Stahl W. L., Swanson P. D. Biochemical abnormalities in Huntington's chorea brains. Neurology. 1974 Sep;24(9):813–819. doi: 10.1212/wnl.24.9.813. [DOI] [PubMed] [Google Scholar]
  19. Tolis G., Pinter E. J., Friesen H. G. The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man. Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):281–283. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES